Cell-free DNA and Risk of HCC in Treated HBV Patients Cell-free DNA and Risk of HCC in Treated HBV Patients

This study investigated whether different species of serum circulating cfDNA may be involved in the process of hepatocarcinogenesis in chronic HBV patients receiving oral antiviral therapy.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news